Kailera Therapeutics, Inc. (KLRA)

NASDAQ: KLRA · Real-Time Price · USD

16.60

-0.45 (-2.64%)

Jul 31, 2026, 10:44 AM EDT - Market open

Kailera Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025
Operating Income	-158.34	-158.34
Net Income	-148.96	-148.96
Earnings Per Share	-949.00	-949.00
EPS Growth	-	-

Cash & Debt

Fiscal Year	Current	FY 2025
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025
Cash & Investments	519.17	546.06
Total Debt	10.47	10.75
Net Cash (Debt)	508.7	535.3
Net Cash Growth	-	-
Net Cash Per Share	16983.41	3409573.25

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025
Operating Cash Flow	-120.21	-120.21
Capital Expenditures	-2.09	-2.09
Free Cash Flow	-122.3	-122.3
Free Cash Flow Growth	-	-